Protection against the omicron variant from previous SARS-CoV-2 infection
| Author | Altarawneh, Heba N. |
| Author | Chemaitelly, Hiam |
| Author | Hasan, Mohammad R. |
| Author | Ayoub, Houssein H. |
| Author | Qassim, Suelen |
| Author | AlMukdad, Sawsan |
| Author | Coyle, Peter |
| Author | Yassine, Hadi M. |
| Author | Al-Khatib, Hebah A. |
| Author | Benslimane, Fatiha M. |
| Author | Al-Kanaani, Zaina |
| Author | Al-Kuwari, Einas |
| Author | Jeremijenko, Andrew |
| Author | Kaleeckal, Anvar H. |
| Author | Latif, Ali N. |
| Author | Shaik, Riyazuddin M. |
| Author | Abdul-Rahim, Hanan F. |
| Author | Nasrallah, Gheyath K. |
| Author | Al-Kuwari, Mohamed G. |
| Author | Butt, Adeel A. |
| Author | Al-Romaihi, Hamad E. |
| Author | Al-Thani, Mohamed H. |
| Author | Al-Khal, Abdullatif |
| Author | Bertollini, Roberto |
| Author | Tang, Patrick |
| Author | Abu-Raddad, Laith J. |
| Available date | 2022-06-13T05:37:34Z |
| Publication Date | 2022-03-31 |
| Publication Name | New England Journal of Medicine |
| Identifier | http://dx.doi.org/10.1056/NEJMc2200133 |
| Citation | Altarawneh HN, Chemaitelly H, Hasan MR, Ayoub HH, Qassim S, AlMukdad S, Coyle P, Yassine HM, Al-Khatib HA, Benslimane FM, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Tang P, Abu-Raddad LJ. Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. N Engl J Med. 2022 Mar 31;386(13):1288-1290. doi: 10.1056/NEJMc2200133. |
| ISSN | 00284793 |
| Abstract | Natural infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits strong protection against reinfection with the B.1.1.7 (alpha),1,2 B.1.351 (beta),1 and B.1.617.2 (delta)3 variants. However, the B.1.1.529 (omicron) variant harbors multiple mutations that can mediate immune evasion. We estimated the effectiveness of previous infection in preventing symptomatic new cases caused by omicron and other SARS-CoV-2 variants in Qatar. In this study, we extracted data regarding coronavirus disease 2019 (Covid-19) laboratory testing, vaccination, clinical infection data, and related demographic details from the national SARS-CoV-2 databases, which include all results of polymerase-chain-reaction (PCR) testing, vaccinations, and hospitalizations and deaths for Covid-19 in Qatar since the start of the pandemic. |
| Language | en |
| Publisher | Massachusetts Medical Society |
| Subject | SARS-CoV-2 Omicron Variant COVID-19 |
| Type | Other |
| Pagination | 1288-1290 |
| Issue Number | 13 |
| Volume Number | 386 |
| ESSN | 1533-4406 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Research Center Research [740 items ]
-
COVID-19 Research [838 items ]